Despite being a net seller of publicly traded stocks in the quarter, Warren Buffett and Berkshire Hathaway added six new companies to the portfolio and made several significant changes. (Photo by: ...
(1) Average MBS, repurchase agreements and stockholders’ equity balances are calculated using two data points, the beginning and ending balances. (2) Portfolio yields and costs of funds are calculated ...
Tanruprubart (formerly ANX005) for GBS Advancing Through Regulatory Interactions; MAA Submission in Europe Anticipated in First Quarter of 2026; Ongoing Discussions with FDA Regarding Generalizability ...
Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution
Kiniksa is recruiting patients in the dose-focusing portion of the Phase 2/3 clinical trial of KPL-387 in recurrent pericarditis. The company expects data from this portion of the trial in the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results